Dapagliflozin

Dapagliflozin

Cas Number :

461432-26-8

Application :

Treat Type 2 Diabetes, Chronic (Long-term) Heart Failure And Chronic Kidney Disease

Dapagliflozin is a cutting-edge medication designed to help manage blood sugar levels in individuals with type 2 diabetes. Its innovative mechanism of action promotes glucose excretion through urine, providing a promising solution for better diabetes management.

Product Description

Specification Value
Medication Type Anti-diabetic medication
Generic Name Dapagliflozin
Brand Name Varied (depending on brand)
Indication Type 2 Diabetes
Mechanism of Action Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor
Dosage Forms Tablets
Typical Dosage Range 5 mg to 10 mg once daily
Administration Oral
Efficacy Reduces blood glucose levels
Side Effects Potential for urinary tract infections, increased urination, and hypoglycemia
Storage Store at room temperature, away from moisture and heat

Product inquiry form

Open chat
1
Scan the code
Hello
Can we help you?
Call Now Button